Publikationer

  1. Efficacy of Dialkylcarbamoylchloride-Coated Dressing in Management of Colonized or Infected Neonatal and Pediatric Wounds. Boyar V. J Wound Ostomy Continence Nurs. 2016;43(5):547-550.
  2. Randomized Controlled Trial Evaluating Dialkylcarbamoyl Chloride Impregnated Dressings for the Prevention of Surgical Site Infections in Adult Women Undergoing Cesarean Section. Stanirowski PJ, Bizoń M, Cendrowski K, Sawicki W. Surg Infect (Larchmt). 2016 Feb 18. [Epub ahead of print]
  3. Dialkylcarbamoyl chloride-impregnated dressing for the prevention of surgical site infection in women undergoing cesarean section: a pilot study. Paweł J. Stanirowski, Anna Kociszewska, Krzysztof Cendrowski, Włodzimierz Sawicki. Arch Med Sci 2016; 12, 2: DOI: 10.5114/aoms.2015.47654
  4. Hydrogel-impregnated dressings for graft fixation: a case series. J-S. Choi, J-H. Lee, S-M. Kim, Y-J. Kim, J-Y. Choi, Y-J. Jun. J Wound Care. 2015 Jul;24(7):326-8. doi: 10.12968/jowc.2015.24.7.326.
  5. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. G. Mosti, MD,  A. Magliaro, V. Mattaliano, P. Picerni, N. Angelotti, MD.  J Wound Care. 2015 Mar;24(3):121-2; 124-7. doi: 10.12968/jowc.2015.24.3.121.
  6. Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings. S. Geroult, R.O. Phillips, C. Demangel. J Wound Care. 2015 Mar;24(3):121-2; 124-7. doi: 10.12968/jowc.2015.24.3.121.
  7. Use of Bacteria- and Fungus-Binding Mesh in Negative Pressure Wound Therapy Provides Significant Granulation Tissue Without Tissue Ingrowth. Malin Malmsjö, Sandra Lindstedt, Richard Ingemansson,  Lotta Gustafsson. Eplasty. 2014 Jan 17;14:e3. eCollection 2014.
  8. Adhesion of meticillin-resistant Staphylococcus aureus to DACC-coated dressings. A.C. Ronner, J. Curtin, N. Karami, U. Ronner. J Wound Care. 2014 Oct;23(10):484, 486-8. doi: 10.12968/jowc.2014.23.10.484.
  9. Comparison of bacteria and fungus-binding mesh, foam and gauze as fillers in negative pressure wound therapy – pressure transduction, wound edge contraction, microvascular blood flow and fluid retention. Malmsjö M, Ingemansson R, Lindstedt S et al. Int Wound J 2012; doi: 10.1111/j.1742-481X.2012.01029.x
  10. Effect of a DACC dressing on the growth properties and proliferation rate of cultured fibroblasts. P. Falk, M.L. Ivarsson. Journal of Wound Care, Vol. 21, Iss. 7 , 12 Jul 2012, pp 327 – 332
  11. Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™. Gentili V, Gianesini S, Balboni PG, Menegatti E, Rotola A, Zuolo M, Caselli E, Zamboni P, Di Luca D. Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1523-9.
  12. Cutimed Sorbact® Made Easy. Probst A, Norris R, Cutting KFWounds international 2012; 3(2):1-6.
  13. The use of DACC-coated dressings for the treatment of infected, complex abdominal wounds. Bullough L, Little G, Hodson J et al. Wounds UK, 2012, Vol 8 , No 4; 102-109.
  14. Using Cutimed Sorbact® Hydroactive on chronic infected wounds. Bruce Z. Wounds UK, 2012, vol 8, No 1;119-129.
  15. Use of DACC-coated antimicrobial dressing in people with diabetes and a history of foot ulceration. Haycocks S, Chadwick P, Guttormsen K. Wounds UK, 2011, Vol 7, No 1; 108-114.
  16. Innovative solutions to daily challenges. Derbyshire A. Br J Community Nurs. 2010 Sep;Suppl:S38, S40-45.
  17. The diabetic foot: managing infection using Cutimed Sorbact® dressings. Skinner R, Hampton S. Br J Nurs. 2010 Jun 10-23;19(11):S30, S32-6.
  18. Cutimed Siltec foam and Cutimed Sorbact® gel dressings: a clinical audit. Stephen-Haynes J, Leak K, Timmmons J et al. Wounds UK, 2010, Vol 6, No1 130-136.
  19. Open study on the topical treatment of interdigital fungal infections in diabetic patients. Johansson A, Ljungh A, Apelqvist J. J Wound Care. 2009 Nov;18(11):470, 472-3.
  20. Evaluating Cutimed Sorbact®: using a case study approach. Powell G. Br J Nurs. 2009 Aug 13-Sep 9;18(15):S30, S32-6.
  21.  Cutimed Sorbact® gel: A new infection management dressing.Pirie G, Duguid K, Timmons J. Wounds UK, 2009, vol 5, No 2; 74-78.
  22.  An investigation of Cutimed Sorbact® as an antimicrobial alternative in wound management. Kammerlander G, Locher E, Suess-Burgart et al. Wounds UK,. 2008, Vol 4, No 2; 10-18.
  23. An evaluation of the efficacy of Cutimed Sorbact® in different types of non-healing wounds. Hampton S. Wounds UK. 2007, Vol 3, No 4; 113-119.
  24. Using the principle of hydrophobic interaction to bind and remove wound bacteria. Ljungh A, Yanagisawa N, Wadström T.  J Wound Care. 2006 Apr;15(4):175-180.
  25. Clinical Evaluation of Sorbact® (Bacteria adsorbing dressing) in the treatment of infected pressure sores. Mussi C, Salvioli G. Acta Vulnologica 2004 Vol. 2, N 1-2; 9-11.
  26. Hydrophobic material in routine umbilical cord care and prevention of infections in newborn infants. Meberg A, Schøyen R. Scand J Infect Dis. 1990;22(6):729-33.